Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China
Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China have?
Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China has 39 citations in the OpenAlex counts ScholarIQ stores.
When was Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China published?
Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China has 2020 year in the ScholarIQ index.
What is the open-access status of Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China?
Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China has gold oa status in the ScholarIQ index.
What is the DOI of Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China?
The DOI for Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China is on the source record.
What is the PMID of Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China?
The PMID for Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China is on the source record.
What is the OpenAlex record for Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China?
The OpenAlex for Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China is on the source record.